• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Novartis US Pharma need female leadership

We definitely should promote and hire based on gender as opposed to merit.

What "we" should do is bring Duane Kalsinsky back to run C.R.M. as soon as possible. Whatever it takes, whatever he wants, money is no object.
He is a brilliant tactician, and his visionary strategies are sorely missed.
Offices miss their free shit, and nobody who is currently in charge wants to give away millions in free product.
It seems current management wants to attach actual value to our products instead of treating them like dental floss samples from the orthadontist.
Men, women, transgender; you all wish you were half the leader Duane was.
Come back Duane, we miss you!